Study In Vivo Intraocular Biocompatibility of In Situ Gelation Hydrogels: Poly(2-Ethyl Oxazoline)-Block-Poly(ε-Caprolactone)-Block-Poly(2-Ethyl Oxazoline) Copolymer, Matrigel and Pluronic F127

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Hwang, Yih Shiou ^a,b   Chiang, Ping Ray ^c   Hong, Wei Hsin ^b   Chiao, Chuan Chin ^c   Chu, I Ming ^c   Hsiue, Ging Ho ^c,d   Shen, Chia Rui ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COPOLYMER; DRUG CARRIER; MATRIGEL; POLOXAMER; POLY(2 ETHYLOXAZOLINE) BLOCK POLY(EPSILON CAPROLACTONE) BLOCK POLY(2 ETHYLOXAZOLINE) COPOLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CATARACTOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; EYE TOXICITY; FEMALE; GELATION; HEAT SENSITIVITY; HYDROGEL; IN VIVO STUDY; NEUROTOXICITY; NONHUMAN; RABBIT; RETINA; SENSORY SYSTEM ELECTROPHYSIOLOGY; TURBIDITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; COLLAGEN; DRUG CARRIERS; DRUG COMBINATIONS; FEMALE; HYDROGELS; LAMININ; POLOXAMER; POLYAMINES; POLYESTERS; PROTEOGLYCANS; RABBITS; RETINA;

EID: 84879718965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067495     Document Type: Article

References (45)

1. Bhattarai N, Gunn J, Zhang M, (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Advanced drug delivery reviews 62: 83-99.
2. Bian L, Zhai DY, Tous E, Rai R, Mauck RL, et al. (2011) Enhanced MSC chondrogenesis following delivery of TGF-[beta] 3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 32: 6425-6434.
3. Derwent JJK, Mieler WF, (2008) Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. Transactions of the American Ophthalmological Society 106: 206-214.
4. Kloxin AM, Tibbitt MW, Anseth KS, (2010) Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms. Nature Protocols 5: 1867-1887.
5. Peng K, Tomatsu I, Korobko AV, Kros A, (2009) Cyclodextrin¡Vdextran based in situ hydrogel formation: a carrier for hydrophobic drugs. Soft Matter 6: 85-87.
6. Tan H, Ramirez CM, Miljkovic N, Li H, Rubin JP, et al. (2009) Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 30: 6844-6853.
7. Wang CH, Hwang YS, Chiang PR, Shen CR, Hong WH, et al. (2012) Extended release of bevacizumab by thermosensitive biodegradable and biocompatible hydrogel. Biomacromolecules 13: 40-48.
8. Deng J, Luo Y, Zhang LM, (2011) PEGylated polyamidoamine dendron-assisted encapsulation of plasmid DNA into in situ forming supramolecular hydrogel. Soft Matter 7: 5944-5947.
9. Choi BG, Park MH, Cho SH, Joo MK, Oh HJ, et al. (2010) In situ thermal gelling polypeptide for chondrocytes 3D culture. Biomaterials 31: 9266-9272.
10. Ferris F 3rd, Fine S, Hyman L (1984) Age-related macular degeneration and blindness due to neovascular maculopathy. Archives of ophthalmology 102: 1640-1642.
11. Miller JW, Adamis AP, Aiello LP, (1997) Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes/metabolism reviews 13: 37-50.
12. Penn J, Madan A, Caldwell R, Bartoli M, Caldwell R, et al. (2008) Vascular endothelial growth factor in eye disease. Progress in retinal and eye research 27: 331-371.
13. Andreoli CM, Miller JW, (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Current opinion in ophthalmology 18: 502-508.
14. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, et al. (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431.
15. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, et al. (2008) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. American journal of ophthalmology 145 239-248: e235.
16. Misra GP, Singh RSJ, Aleman TS, Jacobson SG, Gardner TW, et al. (2009) Subconjunctivally implantable hydrogels with degradable and thermoresponsive properties for sustained release of insulin to the retina. Biomaterials 30: 6541-6547.
17. Turturro SB, Guthrie MJ, Appel AA, Drapala PW, Brey EM, et al. (2011) The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function. Biomaterials 32: 3620-3626.
18. Kitahara S, Morikawa S, Shimizu K, Abe H, Ezaki T, (2010) Alteration of angiogenic patterns on B16BL6 melanoma development promoted in Matrigel. Medical Molecular Morphology 43: 26-36.
19. Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Morikawa S, et al. (2010) Controlled release and antitumor effect of pluronic F127 mixed with cisplatin in a rabbit model. Cardiovascular and interventional radiology 33: 135-142.
20. Oh SH, Kim JH, Song KS, Jeon BH, Yoon JH, et al. (2008) Peripheral nerve regeneration within an asymmetrically porous PLGA/Pluronic F127 nerve guide conduit. Biomaterials 29: 1601-1609.
21. Kibbey MC, (1994) Maintenance of the EHS sarcoma and matrigel preparation. Methods in Cell Science 16: 227-230.
22. Kleinman HK, Martin GR, (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15: 378-386.
23. Kwon JW, Han YK, Lee WJ, Cho CS, Paik SJ, et al. (2005) A pilot study. Journal of Cataract & Refractive Surgery 31: 607-613.
24. Gu Z, Alexandridis A, (2004) Osmotic Stress Measurements if Intermolecular Forces in Ordered Assemblies Formed by Solvated Block Copolymers. Macromolecules 37: 912-924.
25. Schlaad H, Diehl C, Gress A, Meyer M, Demirel AL, et al. (2010) Poly (2 oxazoline) s as Smart Bioinspired Polymers. Macromolecular rapid communications 31: 511-525.
26. Luxenhofer R, Sahay G, Schulz A, Alakhova D, Bronich TK, et al. (2011) Structure-property relationship in cytotoxicity and cell uptake of poly (2-oxazoline) amphiphiles. Journal of Controlled Release 153: 73-82.
27. Zhong X, Ji C, Chan AKL, Kazarian SG, Ruys A, et al. (2011) Fabrication of chitosan/poly (ε-caprolactone) composite hydrogels for tissue engineering applications. Journal of Materials Science: Materials in Medicine: 1-10.
28. Sun L, Shen LJ, Zhu MQ, Dong CM, Wei Y, (2010) Synthesis, self assembly, drug release behavior, and cytotoxicity of triblock and pentablock copolymers composed of poly (£ ' caprolactone), poly (L lactide), and poly (ethylene glycol). Journal of Polymer Science Part A: Polymer Chemistry 48: 4583-4593.
29. Hyun H, Kim YH, Song IB, Lee JW, Kim MS, et al. (2007) In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Biomacromolecules 8: 1093-1100.
30. Bae SJ, Joo MK, Jeong Y, Kim SW, Lee WK, et al. (2006) Gelation behavior of poly (ethylene glycol) and polycaprolactone triblock and multiblock copolymer aqueous solutions. Macromolecules 39: 4873-4879.
31. Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, et al. (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460: 225-230.
32. Gong J, Sagiv O, Cai H, Tsang SH, Del Priore LV, (2008) Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp Eye Res 86: 957-965.
33. Shen D, Wen R, Tuo J, Bojanowski CM, Chan CC, (2006) Exacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice. Ophthalmic Res 38: 71-73.
34. Qiu G, Stewart JM, Sadda SV, Freda R, Lee S, et al. (2006) A new model of experimental subretinal neovascularization in the rabbit. Experimental eye research 83: 141-152.
35. Khattak SF, Bhatia SR, Roberts SC, (2005) Pluronic F127 as a cell encapsulation material: utilization of membrane-stabilizing agents. Tissue Engineering 11: 974-983.
36. Shishido SM, Seabra AB, Loh W, Ganzarolli de Oliveira M, (2003) Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release. Biomaterials 24: 3543-3553.
37. Matthew JE, Nazario YL, Roberts SC, Bhatia SR, (2002) Effect of mammalian cell culture medium on the gelation properties of Pluronic® F127. Biomaterials 23: 4615-4619.
38. Davidorf FH, Chambers RB, Kwon OW, Doyle W, Gresak P, et al. (1990) Ocular toxicity of vitreal pluronic polyol F-127. Retina 10: 297-300.
39. Shen WY, Constable IJ, Chelva E, Rakoczy PE, (2000) Inhibition of diclofenac formulated in hyaluronan on angiogenesis in vitro and its intraocular tolerance in the rabbit eye. Graefe's Archive for Clinical and Experimental Ophthalmology 238: 273-282.
40. Kweon H, Yoo MK, Park IK, Kim TH, Lee HC, et al. (2003) A novel degradable polycaprolactone networks for tissue engineering. Biomaterials 24: 801-808.
41. Wolinsky JB, William C III, Colson YL, Grinstaff MW, (2007) Poly (carbonate ester) s Based on Units of 6-Hydroxyhexanoic Acid and Glycerol. Macromolecules 40: 7065-7068.
42. Hsiue GH, Wang CH, Lo CL, Li JP, Yang JL, (2006) Environmental-sensitive micelles based on poly (2-ethyl-2-oxazoline)-b-poly (L-lactide) diblock copolymer for application in drug delivery. International journal of pharmaceutics 317: 69-75.
43. Lee SC, Chang Y, Jin-San Yoon, Kim C, Kwon IC, et al. (1999) Synthesis and micellar characterization of amphiphilic diblock copolymers based on poly (2-ethyl-2-oxazoline) and aliphatic polyesters 1. Macromolecules 32: 1847-1852.
44. Paques M, Guyomard JL, Simonutti M, Roux MJ, Picaud S, et al. (2007) Panretinal, high-resolution color photography of the mouse fundus. Invest Ophthalmol Vis Sci 48: 2769-2774.
45. Marashi SM, Raeiszadeh M, Workman S, Rahbar A, Soderberg-Naucler C, et al. (2011) Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol 127: 1385-1393 e1384.